| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9327524 | Gynecologic Oncology | 2005 | 4 Pages |
Abstract
Daily cisplatin, at 8 mg/m2/day, is a well-tolerated radiosensitizer in cervical carcinoma patients.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Akira Mitsuhashi, Takashi Uno, Naotake Tanaka, Kiyomi Suzuka, Shinichi Tate, Koji Yamazawa, Hideo Matsui, Seiji Yamamoto, Hisao Ito, Souei Sekiya,